Lawrence Blatt
Chief Scientific Officer, INTERMUNE INC.
Companies
- Aligos Therapeutics, Inc.President Mar 4, 2025 to now1
- Aligos Therapeutics, Inc.Board member Oct 15, 2020 to now2
- Aligos Therapeutics, Inc.Chief executive officer Oct 15, 2020 to now2
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Aligos Therapeutics, Inc. ALGS1,866,092 shares3$9.2M at $4.91Oct 27, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Oct 25, 2023Granted 610,277 shares at $0.76 of Aligos Therapeutics, Inc.3
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARAligos Therapeutics, Inc., President
- 2
- 3